Tag: B2c

Bulk drug industry needs to be strengthened’

There is a need to look at strengthening development of the bulk drug industry in India as the country offers tremendous potential in research and development, a senior government official said at the  5th India Pharma Summit.  MUMBAI: There is a need to look at strengthening development of the bulk drug industry in India as the… Read More ›

FDI in pharma doubled during April to December

The government had cleared a Rs 5,168 crore proposal of US-based pharma firm Mylan Inc’s to acquire Indian generic drugs company Agila Specialties.  NEW DELHI: Foreign direct investment in the pharma sector has more than doubled to $1.26 billion during the April-December period of 2013-14 fiscal amid concerns over increasing acquisitions of domestic firms by… Read More ›

GMR may challenge order scrapping user development fee at Hyderabad airport

HYDERABAD: GMR Hyderabad International Airport Ltd is considering challenging the regulator’s order scrapping the user development fee at Rajiv Gandhi International Airport here, a group official said today. The order by the Airports Economic Regulatory Authority (AERA) will have a negative impact on the company’s financials, said Siddharth Kapur, chief financial officer of GMR Infrastructure’s… Read More ›

Tech firms, Indian airlines join hands for flight safety

NEW DELHI: Aviation technology firms are entering the Indian market in a big way, tying up with airlines like Air India, IndiGo and GoAir to provide critical components to enhance flight safety and run their businesses. Air India today signed a MoU with major US firm Honeywell to upgrade the landing and take-off gears of… Read More ›

Private banks at high risk of losing customers: IBM study

NEW DELHI: Private sector banks in India are at a greater risk of losing their customers on account of non-satisfactory services as compared to public sector banks, says a study by technology giant IBM. Conducted by research firm IDC, the study titled ‘Understanding the Indian Retail Banking Customer’ says push marketing is fast becoming obsolete… Read More ›

Upbeat Boeing and Airbus revise 20-year market outlook for India

As per Boeing outlook, between 2013 and 2032 Indian airlines will buy 1,600 aircraft valued $205 billion.  HYDERABAD: Two of the world’s largest aircraft manufacturers – Boeing and Airbus – have both revised their 20-year market outlook for India stating that the country will see more aircraft sales till 2032 than what they had estimated… Read More ›

A Snapshot of PE activity & deals

Sector-wise allocations in 2013 Capital goods attracted the most investments, accounting for 29.43% of the total investments in terms of deal value, followed by software & services (21.86%) and retailing (16.27%). READ MORE… SOURCE: http://www.business-standard.com

Aviation: Big airlines to fight for a pie in the sky

This year, India emerged as one of the most promisingaviation markets in the world, with three international airlines announcing investment plans here. While Abu Dhabi-basedEtihad Airways sealed a Rs 2,058-crore deal for a 24 per cent stake in Jet Airways, the Tata Group made a resounding comeback in the aviation industry, forging tie-ups for two start-up airline ventures…. Read More ›

Aviation covers to gain newer dimensions in gen insurance

There is rise in demand for cover for ground handling and aircraft components Aviation insurance policies that were primarily used to coverthe fleet of the airline companies is now in demand for the other covers provided by this policy. Insurance companies said that apart from airline insurance, covers for ground handling and aviation product liability has been increasingly being… Read More ›

Small drug firms fear margin erosion will impact long-term growth

As most pharmaceutical companies have recently agreed to revert to the old trade margins for drugs listed under theDrug Price Control Order (DPCO), the move can come as a major blow for small and medium-sized drug firms, which expect erosion in margins as a result. This leaves SME drug makers strapped for cash, jeopardising their chances of diversifying into… Read More ›